hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06260098 id: H23-0617 briefTitle: StressLess Yoga Study overallStatus: RECRUITING date: 2024-04-03 date: 2024-05-30 date: 2024-05-30 date: 2024-02-15 date: 2024-04-05 name: University of Connecticut class: OTHER briefSummary: The purpose of this study is to assess the feasibility and acceptability of using an asynchronous online yoga program to reduce stress. The study will use an 8 week asynchronous yoga intervention of two different types of yoga (high in breath work and meditation; low in vigorous movement/postures vs. low breath work and meditation; high movement/postures). In addition to self-report stress, measures include sleep, heart rate variability, mindfulness, Essential Properties of Yoga, and acceptability questions. conditions: Stress studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 40 type: ESTIMATED name: Yoga with High Breath work & meditation; Low movement/postures name: Yoga with Low Breath work & meditation; High movement/postures measure: The number (percentage)of people completing the whole protocol (6/8 yoga classes & 2 in-person visits) measure: The combined score (out of 35) on the 5-item Treatment Acceptability Questionnaire (TAQ) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Bousfield Psychology Building, 406 Babbidge Road status: RECRUITING city: Storrs state: Connecticut zip: 06269 country: United States name: Crystal Park, PhD role: CONTACT phone: 860-486-3520 email: crystal.park@uconn.edu name: Crystal Park, PhD role: PRINCIPAL_INVESTIGATOR lat: 41.80843 lon: -72.24952 hasResults: False
nctId: NCT06260085 id: 686 briefTitle: Effect of Listening to Relatives' Voice Recordings on Chest Pain, Anxiety, and Depression in Coronary ICU Patients overallStatus: COMPLETED date: 2022-06-04 date: 2023-07-04 date: 2023-09-04 date: 2024-02-15 date: 2024-02-15 name: T.C. ORDU ÜNİVERSİTESİ class: OTHER briefSummary: The aim of the study was to evaluate the effect of listening to the voice recordings of relatives of patients with acute myocardial infarction (AMI) who were treated in the coronary intensive care unit on chest pain, anxiety and depression parameters of the patients.
Methods In the study, which was conducted as a randomised, controlled, experimental study, voice recordings of the family members of the patients were created and played to the patients through a music pillow. The study was carried out with 60 patients, 30 experimental and 30 control groups. Three tests were applied to the patients 15 minutes before, 15 and 30 minutes after the application. The data of the study were collected using the "Patient Introduction Form", "Hospital Anxiety Depression Scale", "Visual Analogue Scale" and "Patient Follow-up Form". conditions: Acute Myocardial Infarction conditions: Intensive Care Unit Syndrome studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE maskingDescription: The clinical nurse collected the data whoMasked: OUTCOMES_ASSESSOR count: 60 type: ACTUAL name: Relatives vioce record measure: Chest Pain measure: Anxiety, and Depression sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Yasemin Kalkan Uğurlu city: Ordu zip: 52200 country: Turkey lat: 40.97782 lon: 37.89047 hasResults: False
nctId: NCT06260072 id: IRB-HSR 21920 briefTitle: Magnesium and Riboflavin Treatment for Post-Concussion Headache overallStatus: RECRUITING date: 2020-02-10 date: 2024-12-31 date: 2024-12-31 date: 2024-02-15 date: 2024-02-16 name: University of Virginia class: OTHER briefSummary: This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person. conditions: Concussion, Intermediate studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 108 type: ESTIMATED name: magnesium and riboflavin supplement measure: Headache Intensity and Duration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Virginia Student Health and Wellness Center status: RECRUITING city: Charlottesville state: Virginia zip: 22903 country: United States name: Karen Ahern, BSN MBA role: CONTACT phone: 434-924-1549 email: kaa7p@virginia.edu lat: 38.02931 lon: -78.47668 hasResults: False
nctId: NCT06260059 id: STUDY23070148 id: Pitt2024 type: OTHER_GRANT domain: Pittsburgh Foundation briefTitle: Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease acronym: EmpaCHD overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2026-12-31 date: 2027-06-01 date: 2024-02-15 date: 2024-02-15 name: Anita Saraf class: OTHER name: The Pittsburgh Foundation briefSummary: The goal of the study is to investigate the feasibility and benefit of novel guideline-directed heart failure therapy drug Empagliflozin (Jardiance) for adult patients with congenital heart disease (ACHD). conditions: Adult Congenital Heart Disease conditions: Heart Failure studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Group 1: Empagliflozin 10 MG daily Group 2: Placebo primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: Empagliflozin 10 MG name: Placebo measure: Change in Ejection fraction (EF) measure: Change in Myocardial characteristics (T1 mapping of cMRI) measure: Change in Myocardial characteristics (Global strain on MRI) measure: Change in Myocardial characteristics (Global strain on echocardiogram) measure: Change in functional exercise capacity of participants. measure: Number of Participants Hospitalized for Cardiac Reasons or heart transplantation measure: Number of Deaths measure: Change in inflammatory serum biomarkers measure: Change in functional Neuropsychological Testing measure: Change in New York Heart Association (NYHA) Class measure: Change Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Change in Kansas City Cardiomyopathy (KCCQ) measure: Change in Neuro-QOL sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Magee Women's Hospital city: Pittsburgh state: Pennsylvania zip: 15213 country: United States lat: 40.44062 lon: -79.99589 facility: Presbyterian Hospital city: Pittsburgh state: Pennsylvania zip: 15213 country: United States lat: 40.44062 lon: -79.99589 facility: Children's Hospital of Pittsburgh city: Pittsburgh state: Pennsylvania zip: 15224 country: United States lat: 40.44062 lon: -79.99589 hasResults: False
nctId: NCT06260046 id: Robot Nx-SFTN briefTitle: Effect of Sufentanil on the Postoperative Pain overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-01-15 date: 2027-01-15 date: 2024-02-15 date: 2024-02-15 name: Seoul National University Hospital class: OTHER briefSummary: This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery. conditions: Postoperative Pain, Acute studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 48 type: ESTIMATED name: Sufentanil name: Remifentanil measure: opioid consumption measure: Richmond Agitation-Sedation scale measure: Incidence of postoperative nausea and vomiting measure: Number of patients who administered antiemetics measure: Pain score sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Seoul National University Bundang Hospital city: Seongnam country: Korea, Republic of name: Chang-Hoon Koo role: CONTACT email: vollock9@gmail.com lat: 37.43861 lon: 127.13778 hasResults: False